Retrospective clinical study for albumin leakage and survival between hemodialysis and online hemodiafiltratio
Not Applicable
- Conditions
- Patients with end-stage renal failure undergoing hemodialysis
- Registration Number
- JPRN-UMIN000047948
- Lead Sponsor
- Kawashima hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
1 Under 20 years of age 2 Dialysis conditions including dialysis method, dilution method, substitution volume, membrane material between April 1, 2017 and June 30, 2017, which are different from those as of July 1, 2017 3 Blood purification methods other than HD or OHDF 4 Dialysis frequency below 3 sessions per week or dialysis time below 3 hour per session 5 Substitution volume of less than 60 L in predilution OHDF and less than 8 L in postdilution OHDF 6 Pregnant or lactating patients 7 Missing values of variables at the start of the study 8 Beta2 microglobulin clearance less than 70 mL per min
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year all-cause mortality during 3 yearss between super high-flux HD with high albumin leakage and OHDF with low albumin leakage
- Secondary Outcome Measures
Name Time Method